All Stories

  1. Chalcones identify cTXNPx as a potential antileishmanial drug target

    Article • PLoS Neglected Tropical Diseases, November 2021, PLOS

    Bartira Rossi-Bergmann

  2. Nanoparticles Loaded with a New Thiourea Derivative: Development and In Vitro Evaluation Against Leishmania Amazonensis

    Article • Current Drug Delivery, July 2020, Bentham Science Publishers

    Bartira Rossi-Bergmann

  3. Broad Spectrum and Safety of Oral Treatment with a Promising Nitrosylated Chalcone in Murine Leishmaniasis

    Article • Antimicrobial Agents and Chemotherapy, July 2018, ASM Journals

    Bartira Rossi-Bergmann

  4. Improved drug loading via spray drying of a chalcone implant for local treatment of cutaneous leishmaniasis

    Article • Drug Development and Industrial Pharmacy, April 2018, Taylor & Francis

    Bartira Rossi-Bergmann

  5. Depot Subcutaneous Injection with Chalcone CH8-Loaded Poly(Lactic-Co-Glycolic Acid) Microspheres as a Single-Dose Treatment of Cutaneous Leishmaniasis

    Article • Antimicrobial Agents and Chemotherapy, December 2017, ASM Journals

    Bartira Rossi-Bergmann

  6. Lipid-core nanocapsules increase the oral efficacy of quercetin in cutaneous leishmaniasis

    Article • Parasitology, June 2017, Cambridge University Press

    Bartira Rossi-Bergmann

  7. Anti-parasitic effect of the diuretic and Na+-ATPAse inhibitor furosemide in cutaneous leishmaniasis

    Article • Parasitology, June 2017, Cambridge University Press

    Bartira Rossi-Bergmann

  8. Synthesis and characterization of poly(N-vinylcaprolactam)-based spray-dried microparticles exhibiting temperature and pH-sensitive properties for controlled release of ketoprofen

    Article • Drug Development and Industrial Pharmacy, May 2017, Taylor & Francis

    Bartira Rossi-Bergmann